London South East | The UK's favourite investor portal.

RNS Number : 0040L Havelock Europa PLC 29 April 2010  Thursday 29 April 2009 HAVELOCK EUROPA PLC - PRELIMINARY ANNOUNCEMENT Havelock (HVE.L), the retail and educational interiors and point of sale printing group, announces its results for the year to 31 December 2009. Key points - financial · Revenue decreased by 21% to £108.5m. · The underlying† pre-tax result was a loss of £2.0m (2008: profit of £8.0m), a fully diluted loss per share of 3.1p (2008: EPS of 14.9p). · The reported pre-tax loss was £5.9m (2008: profit of £7.7m), a fully diluted loss per share of 10.7p (2008: EPS of 14.1p). · Year end net debt increased to £19.4m (2008: £11.7m). Havelock has now agreed new bank facilities totalling £33m, which the Board considers adequate. · No final dividend is proposed and no dividends for 2010 are expected. † Underlying excludes exceptional costs of £3.6m (2008: nil) and amortisation of intangibles (other than software) of £0.3m (2008: £0.3m) Key points - commercial · Educational Interiors revenue increased by 9% to £56.8m, but the Division made a loss, principally caused by the effects encountered in the integration of the IT systems and operations of ESA McIntosh and Retail Interiors. · Retail Interiors revenue reduced by 47% to £31.9m, as all customers reduced expenditure, and the Division also made a loss. · Revenue in Point of Sale Printing reduced by 21% to £19.7m, but the Division continued to make a satisfactory level of profit, with gross margins maintained as a result of recent investment in modern equipment. Key point - Board · The Board's search for a new permanent Chief Executive is well underway. Current trading and prospects Malcolm Gourlay, Chairman, said: "Since the year end, Havelock has experienced an encouraging increase in the level of enquiries and in new orders received. The Board believes that it has rectified the operational issues which arose in 2009 and that the cost savings generated through the integration are now being realised. It is looking for opportunities to increase the level of savings above the £2m per annum achieved so far. The Board's expectation for the half year is for the Interiors Division to trade at a lower level than in 2009 but with a second half performance in line with the historical pattern of a strong second half emphasis reflecting the demands of our retail and education customers. Since the end of the year, the Group has incurred exceptional costs relating to its refinancing and Board reorganisation, and its current cost saving programmes will lead to further one-off costs. For the full year,

RNS Number : 0031L Alexander David Securities Grp PLC 29 April 2010  Alexander David Securities Group Plc ("Alexander David Securities" or the "Company") Financial Statements For the year ended 31 December 2009 Alexander David Securities Group Plc is pleased to announce its preliminary results for the year to 31 December 2009. FINANCIAL HIGHLIGHTS · Turnover increased by 122% to £2,276,000 (2008: £1,025,000) · Reduction in the loss for the year to £557,000 (2008: £975,000) · Improved trading throughout the period and was profitable in the last quarter · Strong trading continued into the first quarter of 2010 · Advisory funds increased 80% to £30.7m (2008 £17m) BUSINESS HIGHLIGHTS · Continued expansion of staff numbers in Corporate Broking and Corporate Finance advisory teams · Continued growth in trading volumes in equities and CFD's in the Private Client division · Strengthening institutional sales and corporate broking desks · As at 31 December 2009, the Group had 892 private clients (2008: 692), an increase of 30% · Alexander David Securities advised on 20 corporate transactions in the year · Corporate broking clients at the year end rose from nine in 2008 to thirteen in 2009 · Despite difficult market conditions we continued to raise funds for existing and new corporate clients of the Group Michael Hicks, Chairman, commented "This has been a challenging year for Alexander David Securities, however the year under review has finished strongly and we are continuing to witness encouraging results from the first quarter of 2010." CHAIRMAN'S STATEMENT I am delighted to present the results

RNS Number : 9337K Galantas Gold Corporation 28 April 2010  GALANTAS GOLD CORPORATION MANAGEMENT DISCUSSION AND ANALYSIS Year ended December 31, 2009 This document constitutes management's discussion and analysis (MD&A) of the financial and operational results of Galantas Gold Corporation (the Company) for the year ended December 31, 2009. This MD&A supplements, but does not form part of the consolidated financial statements of the Company, and should be read in conjunction with the audited consolidated financial statements and related notes for the year ended December 31, 2009. The Company prepares and files its financial statements in accordance with Canadian Generally Accepted Accounting Principles ("GAAP"). The currency referred to in this document is the Canadian dollar. The MD&A is prepared in conformance with National Instrument 51-102F1 and was approved by the Company's Audit Committee on April 26, 2010. FORWARD LOOKING STATEMENTS The information in the MD&A contains forward looking statements, including statements about anticipated operating and financial performance. Such statements are not guarantees of future performance which is subject to risks and uncertainties only some of which are within the Company's control, and any or all of which could cause the Company's performance to be materially different from what directors may believe. Given the uncertainties associated with forward looking statements, readers are cautioned not to place undue reliance on them. The Company does not undertake to update any forward looking statements contained herein. OVERVIEW - STRATEGY - DESCRIPTION OF BUSINESS Company Overview Galantas Gold Corporation is a producing mineral resource issuer and the first to acquire planning consent to mine gold in Northern Ireland. The Company's wholly owned Ontario holding company, Cavanacaw Corporation, owns all of the shares of two Northern Ireland companies - Omagh Minerals Limited, owner of prospecting and mining rights, planning consent plus land, buildings and equipment; and Galantas Irish Gold Limited, owner of rights to work, market and sell part of the Company's gold production as certified Irish gold jewellery. Mining at the Omagh mine is conducted by open pit methods. The mine produces a flotation concentrate most of which is shipped to a smelter in Canada under a life of mine off-take agreement. Some concentrate is occasionally set aside from that sold to the smelter for separate processing in a specialist facility. The gold produced by the separate facility becomes feed - stock for the Galantas Irish gold jewellery business. The Company's strategy to increase shareholder value is to: · Increase the production of the open pit mine and processing plant on its Kearney deposit, · Continue to ex

TORONTO, ONTARIO--(Marketwire - April 28, 2010) - Galantas Gold Corporation (TSX VENTURE:GAL)(AIM:GAL) (the Company) has announced annual audited results for the year to December 31st 2009. These demonstrate a positive cash flow for the year of $545,828 and this positive trend continues in the first quarter. The net loss for the year ended December 31, 2009 amounted to $ 6,361,397 compared to a restated loss of $ 2,452,220 for the year ended December 31, 2008. When the Net Loss is adjusted for non cash items the cash generated from operating activities amounted to $ 545,828 for the year ended December 31, 2009 compared to $ 39,670 for the year ended December 31, 2008. The primary reason for the increased loss in 2009 is due to an impairment charge totalling $ 5,314,412 on both deferred development and exploration ($ 3,448,716) and property, plant and equipment costs ($1,865,676) during 2009. This impairment of assets is a write down of the Company's assets as a result of the fair value of the Company's assets being less than estimated carrying value. This difference between the carrying value and the discounted future cash flow has been recognized as an impairment. The Company is restating the comparative figures in the current year's consolidated financial statements to reverse the future tax asset that had been recognized in the prior years. Highlights of the 2009 annual results, which are expressed in Canadian Dollars, are: 2009 2008 Revenue $ 5,409,913 $ 4,402,965 Cost of Sales $ 3,692,087 $ 3,909,656 Amortization $ 1,666,992 $ 1,558,679 Income (loss) before Other Costs/Income $ 51,134 $ (1,065,370) Impairment of Assets $ 5,314,412 $ 0 Other Costs/(Income) $ 1,098,419 $ 1,386,850 Net Income (loss) for the year $ (6,361,697) $ (2,452,220) Net Cash Flow from Operating Activities $ 545,828 $ 39,670 The detailed results and Management Discussion and Analysis (MD&A) are available on www.sedar.com and www.galantas.com and the highlights in this release should be read in conjunction with the detailed results and MD&A. The MD&A provides an analysis of comparisons with previous periods, trends affecting the business and risk factors. Production Update for the first quarter 2010. The Company has received provisional production tonnages for the first quarter (January - March 2010 (Q1) from its wholly owned subsidiary Omagh Minerals Limited (OML). OML operates the only gold mine in Ireland and produces a concentrate containing gold, silver and lead. January's production was 137.8 wet tonnes of concentrate. February saw 259.6 wet tonnes of concentrate produced, with March's production measuring 250.7 wet tonnes, a total of 648.1 wet tonnes for the quarter (599 dry tonnes). Gold production was 42% higher than the same quarter in 2009 and 37% higher than the fourth quarter of 2009. The metal content of the concentrate remains to be fully assessed, though it is anticipated that shipments for the first quarter contained approximately 66.8 kgs (2

TIDMFUL RNS Number : 9149K Fulcrum Pharma PLC 28 April 2010 ? NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY RESTRICTED JURISDICTION (INCLUDING THE UNITED STATES, AUSTRALIA, CANADA AND JAPAN) OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE 28 April 2010 RECOMMENDED CASH OFFER by GOLD MEDAL ACQUISITIONS UK LIMITED for FULCRUM PHARMA PLC Summary · The boards of Gold Medal Acquisitions UK Limited ("Gold Medal UK") and Fulcrum Pharma plc ("Fulcrum Pharma" or the "Company") are pleased to announce the terms of a recommended cash offer, to be made by Gold Medal UK for the entire issued and to be issued share capital of Fulcrum Pharma (the "Offer"). · The Offer will comprise 5.85 pence in cash for each Fulcrum Pharma Share (the "Offer Price"). · The Offer values the entire issued and to be issued share capital of Fulcrum Pharma at approximately GBP11.56 million. · The Offer Price represents a premium of approximately: o 73 per cent. to the Closing Price of 3.375 pence per Fulcrum Pharma Share on 27 April 2010, being the last Business Day prior to this Announcement; and o 83 per cent. to the average Closing Price of 3.20 pence per Fulcrum Pharma Share for the six month period ended 27 April 2010, being the last Business Day prior to this Announcement. · The Independent Directors, who have been so advised by Singer Capital Markets, consider the terms of the Offer to be fair and reasonable. In providing advice to the Independent Directors, Singer Capital Markets has taken into account the commercial assessments of the Independent Directors. · Accordingly, the Independent Directors intend unanimously to recommend that Fulcrum Pharma Shareholders accept the Offer. · The Fulcrum Pharma Directors have irrevocably undertaken with Gold Medal UK to accept, or procure the acceptance of, the Offer in respect of their entire beneficial holdings of Fulcrum Pharma Shares, which amount in aggregate to 11,114,563 Fulcrum Pharma Shares, representing, as at the date of this Announcement, approximately 6.25 per cent. of the current issued share capital of Fulcrum Pharma and in respect of any Fulcrum Pharma Shares that may be issued to, or acquired by, them pursuant to the exercise of options they hold over Fulcrum Pharma Shares. · Certain other Fulcrum Pharma Shareholders (not being Fulcrum Pharma Directors) have irrevocably undertaken to accept, or procure the acceptance of, the Offer in respect of certain of their respective beneficial holdings of Fulcrum Pharma Shares which amount, in aggregate, to 45,161,603 Fulcrum Pharma Shares, representing, as at the date of this Announcement, approximately 25.38 per cent. of the current issued share capital of Fulcrum Pharma. · In total, Fulcrum Pharma Shareholders have undertaken to accept, or procure the acce

RNS Number : 9097K Telephonetics PLC 28 April 2010  Telephonetics wins a multi-year contract with Ireland's largest leading cinema operator, Omniplex Cinemas 28 April 2010, Hemel Hempstead, UK - Telephonetics Plc, the speech automation and data integration specialist, announces today the signing of a multi year contract with Omniplex Cinemas including Savoy Cinema Dublin, Screen Cinema Dublin and Swan Cinemas Rathmines for provision of its MovieLINE automatic speech recognition (ASR) film information and ticket booking service to 25 cinema sites in Northern Ireland and The Republic of Ireland. As Ireland's largest leading cinema operator, Omniplex Cinemas account for over 50% of cinema tickets sold in the Republic of Ireland and Northern Ireland. This contract reinforces Telephonetics market leading position for providing film information and ticket booking services to the cinema industry. In the UK, Telephonetics provide the MovieLINE service to 83% of the major multiplex cinemas. In addition, the contract allows the path to open up further to international expansion for Telephonetics. Omniplex have traditionally managed calls for their cinema sites across Northern Ireland and Eire through a centralised call centre. In December 2009, Omniplex made a decision to trial MovieLINE as part of the opening of their new Dublin site -Swan Cinemas in Rathmines. Omniplex were aware that the vast majority of the calls received by the contact centre were for routine and repetitive tasks, such as providing information on films available and taking payments over the telephone, all of which had the potential for automation. The primary reason Omniplex decided to adopt MovieLINE, following the successful trial period, was that during busy times contact centre staff would struggle to efficiently handle peaks in call traffic, leading to unsatisfied customers left hanging on the telephone, which could have resulted in film-goers going elsewhere. Mark Anderson, Operations Director of Omniplex, commented: "Using contact centre agents alone to deal with high call volumes was often challenging, especially during busy peaks such as at the launch of a new film or during adverse weather conditions which often creates a surge in calls as people look for indoor activities. One of our key drivers was ultimately to give our customers better service. We decided to take a trial with Telephonetics to see whether an automated service proved popular with our customers. And it did - calls were immediately handled efficiently and MovieLINE allows our customers near instant access to film information and ticket booking over the telephone, at any time of the day or night." Anthony McKay, CEO of Telephonetics Plc, commented: "We are delighted to welcome Omniplex Cinemas to our family of cinema customers - they will be in great company. This is testamen

RNS Number : 9115K Camco International Ltd 28 April 2010  April 28 2010 Camco's Advisory Business project wins In the first quarter of 2010 Camco's Advisory Business won new contracts amounting to £2.4 million in fees. The main service areas have been energy management, carbon management and sustainable energy solutions. The bulk of the work comes from the private sector mainly the industrial, manufacturing and property sectors. Camco is pleased to report that the first quarter of 2010 was the most profitable first quarter in the history of Camco's Advisory Unit. The Advisory Business has been consistently improving its profitability, reflecting strong management, ongoing restructuring efforts and the improvement of market conditions in the UK. Camco Advisory specialises in energy management and sustainable energy solutions with operations in the UK, Africa, China and the US. With over two decades of operations the Advisory business unit has a unique combination of skills and experience translating into successful low carbon energy and sustainable solutions. Scott McGregor CEO "I am happy to report that the advisory unit has exceeded its targets for the quarter. The unit has turned profitable and has won sizeable contracts reflecting the quality of our work worldwide." Enquiries: Camco +44 (0)20 7121 6100 Scott McGregor, Chief Executive Office Graeme Halder, Chief Financial Officer KBC Peel Hunt Ltd (Nominated Adviser and Broker) +44 (0)20 7418 8900 Jonathan Marren David Anderson Gavin Anderson +44 (0) 20 7074 1800 Ken Cronin Kate Hill Matt O'Leary About Camco Camco is a global emissions reduction company providing project development, advisory and commercial expertise in the clean energy space. Camco has a 20-year track record of operations in China, US, Russia, the UK and Africa, bringing together the distinct but complementary service areas of Carbon, Advisory and Investments to help its clients and partners manage all aspects of reducing emissions. The Carbon business unit has developed one of the largest emission reduction portfolios by working closely with companies to identify and develop projects that reduce greenhouse gas ("GHG") emissions. The team has structured groundbreaking and innovative transactions for the sale and delivery of certified emission reductions to compliance and voluntary buyers. The Advisory business unit combines strategic, commercial, financial and technical expertise accrued over two decades to deliver low carbon energy and sustainable development solutions. Our experience spans emission assessments, carbon management

RNS Number : 7713K Osmetech PLC 26 April 2010  Osmetech Plc (the "Company") Osmetech plc Receives 510(k) Clearance for the eSensor® Thrombophilia Risk Test Osmetech Plc (AIM:OMH) today announced that the US Food and Drug Administration (FDA) has cleared the eSensor® Thrombophilia Risk Test (TRT), a multiplexed molecular diagnostic test for four genetic markers associated with thrombosis. The panel includes Factor V Leiden, Factor II Prothrombin, MTHFR 677 and MTHFR 1298 in a single test panel. Thrombophilia disorders affect roughly 1 in 1,000 individuals, and genetic testing has become an accepted method of assessing an individual's inherited risk for thrombosis and other related cardiovascular events. "The FDA clearance of our Thrombophilia Risk Test marks a significant milestone in the development of our test menu and further demonstrates the value of our proprietary eSensor® electronic DNA detection technology," said Faiz Kayyem, President and CEO of Osmetech, plc. "We believe that Osmetech is the first company to have achieved FDA clearance for all four thrombophilia related genetic markers." The eSensor® Thrombophilia Risk Test is for use on the Company's XT-8 system, a versatile DNA detection platform for hospital and reference laboratories. TRT can be configured to report out single genetic mutation results or various combinations including a Factor V/Factor II only result and the full thrombophilia panel of all four genetic mutations. The eSensor® Thrombophilia Risk Test is the third product cleared by the FDA for use on the XT-8 system and complements existing FDA cleared products for Cystic Fibrosis and Warfarin Sensitivity. Contacts Osmetech plc Steven Kemper, Chief Financial Officer +1 626-463-2004 Jon Faiz Kayyem, Chief Executive Officer +1 626-463-2000 or Canaccord Adams Limited (Nominated Advisor) Robert Finlay 020 7050 6500 Henry Fitzgerald-O'Connor 020 7050 6500 This information is provided by RNS The company news service from the London Stock Exchange END REAIFMLTMBATMPM

RNS Number : 7469K UBC Media Group PLC 26 April 2010  26 April 2010, London UBC Media Group plc ('UBC Media' or the 'Company') UBC announces further radio stations join iPhone 'App' network Further to its announcement on April 14th, UBC Media Group plc ("UBC") is pleased today to announce the signing of agreements with a further 4 radio groups who will join its network of mobile applications based around Apple's iPhone. UBC's software division, Unique Interactive ("UI") is developing and supplying iPhone and other mobile platform applications ("Apps") to radio clients for free in return for selling advertising space within the applications. Revenue from the advertising, which is being sold by the 'Lynx Content' internet advertising business acquired by UBC last year, is then shared between UBC and the radio station client. Today the Jazz FM, Tindle Radio, Orion Media and UKRD/TLRC radio groups join the network, which already includes UTV plc's radio stations and Planet Rock. This brings the total number of radio stations for whom UBC will be producing mobile applications to 45 with a total combined weekly reach of just under 7 million listeners. The purpose-built Apps will allow users to listen to their radio station wherever they have wifi or a mobile signal, but importantly will also provide a wide range of additional features for them to enjoy such as instant programme reminders, listen again and social network interaction. The advertising network will launch early next month with an App for talkSPORT as part of the station's build up to the World Cup, the other stations will launch their Apps over the next 3 months. UBC has experience in the development of advertiser network projects in commercial radio. In 2000 it began to develop a network providing traffic and travel news to the UK radio industry; a business it sold in 2009 to American company Global Traffic Networks for £10.9m in cash. Simon Cole, Chief Executive of UBC said: "The rapid growth of our network demonstrates the momentum in what I believe will become an increasingly important market for radio stations. Consumer habits are changing and streamed listening on mobile devices is the fastest growing area of overall radio listening. I believe that the new iPhone radio network combines perfectly UBC's core strengths of content and related technology and we expect it to be a major part of our commercial offering in the future." - Ends - Notes to Editors About UBC Media Group UBC is the market leader in the supply of audio content to the radio industry in the UK. The Company is the largest independent producer of radio programming for the BBC and a provider of entertainment programming to commercial stations throughout the UK. Its software division, Unique Interactive, is a global supplier of digital radio text and data services. The Comp

Latest Share Chat

Member Info for Globalcrossings

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)

Latest Share Chat

Member Info for Globalcrossings

Followers

Following

Posts (Last 30 Days)

Posts (All Time)

Last Post

Member Since

Share Chat Post Distribution (Last 30 Days)

Activity Log (Last 30 Days)

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending